The Effect of Short Term Solifenacin for Overactive Bladder on the Female Urinary Microbiome
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Pharmacodynamics
- 30 Oct 2015 Trial design has been changed from cohort, observational to interventional, open, parallel as reported by ClinicalTrials.gov record.
- 30 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Sep 2014 Planned End Date changed from 1 Jul 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.